Skip to content
Screener

Arrowhead Research ARWR Business Segments — Stock compensation

Similar metrics at other companies

Comstock Holding Companies, Inc. logo
CHCIReportable Segment — Stock compensation
$546K+118%
Exagen Inc. logo
XGNReportable Segment — Stock compensation
$607K+67.7%
DocGo logo
DCGOCorporate — Stock compensation
$2.61M-27.2%
DocGo logo
DCGOTransportation Services — Stock compensation
$6.65K-88.4%
DocGo logo
DCGOMobile Health Services — Stock compensation
$605.77K-48.8%
Health Catalyst logo
HCATCorporate Segment and Other Operating Segment — Stock-based compensation expense
$417K-72.0%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Six Months Ended March 31, 2026Six Months Ended March 31, 2025
Salaries$12,435$7,857$24,375$15,188
Professional, outside services, and other18,94010,81537,84120,941
Facilities related1,4961,0823,1592,367
Total selling, general and administrative expense, excluding non-cash expense$32,871$19,754$65,375$38,496
Stock compensation8,3738,14021,38615,799
Depreciation/amortization5005111,0041,020
Total selling, general and administrative expense$41,744$28,405$87,765$55,315

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's business segments — stock compensation?
Arrowhead Research (ARWR) reported business segments — stock compensation of $8.37M in Q1 2026.
How has Arrowhead Research's business segments — stock compensation changed year-over-year?
Arrowhead Research's business segments — stock compensation increased by 2.9% year-over-year, from $8.14M to $8.37M.
What does business segments — stock compensation mean?
Represents the non-cash expense recognized for equity-based awards granted to employees and directors. This metric reflects the cost of aligning employee incentives with shareholder interests through stock options or restricted stock units. It is a significant component of total compensation in the biotechnology sector.

Ask your AI about Arrowhead Research's business segments — stock compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude